Objectives: To evaluate the efficacy, safety, and stability of EyeCryl Phakic intraocular lens (IOL) implantation.
Methodology: This retrospective study was conducted in Maghrabi Hospital in Medina to review 31 patients who underwent posterior chamber phakic IOL (EyeCryl Phakic IOL) for surgical correction of myopia or astigmatism. The data were collected from patient medical records after obtaining their consents.
Results: Our findings demonstrated the efficacy of a toric implantable collamer lens (ICL) for the treatment of myopic astigmatism, with a significant change in all eye measures (sphericity, axis, and cylinder) after IOL implantation for study participants in both right and left eyes. There were no intraoperative complications observed among the studied patients; however, one case required ICL repositioning due to spontaneous axis rotation. The majority of cases showed no postoperative complications except one case complaint of steroid-induced glaucoma. In this study, we observed no significant changes regarding endothelial cell loss.
Conclusion: In summary, EyeCryl Phakic IOL implantation may be safe and effective for myopic astigmatism patients. It improved the visual performance of most of the studied participants without detecting serious complications. Studies with longer follow-ups are needed to observe other complications and ensure the safety of the procedure.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11780338 | PMC |
| http://dx.doi.org/10.7759/cureus.76656 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Objectives: To evaluate the efficacy, safety, and stability of EyeCryl Phakic intraocular lens (IOL) implantation.
Methodology: This retrospective study was conducted in Maghrabi Hospital in Medina to review 31 patients who underwent posterior chamber phakic IOL (EyeCryl Phakic IOL) for surgical correction of myopia or astigmatism. The data were collected from patient medical records after obtaining their consents.
One-Year Results of a Posterior Chamber Toric Phakic Intraocular Lens Implantation in Patients with Keratoconus.
Clin Ophthalmol
October 2024
Department of Clinical Research, Black Mammoth Surgical, Medellín, Colombia.
Purpose: To determine clinical and refractive results after the implantation of EyeCryl Phakic Toric intraocular lens in patients with stable keratoconus.
Methods: The study included all patients diagnosed with keratoconus who underwent implantation of an EyeCryl Phakic Toric intraocular lens (Biotech Healthcare Holding; Ahmedabad, India) in at least one eye and had a follow-up of at least 12 months. Visual and refractive data were collected for all patients, along with corneal tomography measurements using Pentacam, and vault measurement using optical coherence tomography.
Three-year outcomes of a novel toric intraocular lens implantation for moderate-high myopic astigmatism in phakic eyes.
BMC Ophthalmol
August 2024
University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Olimpiyat Bulvari Yolu, Basaksehir, Istanbul, 34480, Turkey.
Article Synopsis
- A study was conducted to evaluate the Eyecryl toric phakic IOL (pIOL) for patients with moderate-to-high myopic astigmatism, focusing on visual and refractive outcomes over three years.
- The research included 52 eyes from 28 patients, showing a significant improvement in visual acuity and reduction in astigmatism, with 70% of eyes achieving better vision versus preoperative levels.
- The findings indicate that the Eyecryl toric pIOL is effective and safe, though some patients experienced minor complications, such as cell loss and opacification issues.
Characterization of vault with two models of posterior chamber phakic intraocular lenses.
J Cataract Refract Surg
December 2024
From the Clínica AVER, Madrid, Spain (Paredes, Mora de Oñate, Martín Sánchez); Department of Optics, Pharmacology and Anatomy, University of Alicante, Alicante, Spain (Piñero).
Purpose: To evaluate and compare dynamic vault range (DVR) and asymmetry of the vault during a 3-month follow-up after the implantation of 2 posterior chamber phakic intraocular lenses (pIOLs).
Setting: Aver Clinic, Madrid, Spain.
Design: Prospective comparative study.
Seven-Year clinical outcomes after implantation of Eyecryl posterior chamber phakic intraocular lenses for high myopia.
Eur J Ophthalmol
September 2024
Atakoy World Eye Hospital, Istanbul, Turkey.
Purpose: To evaluate the long-term clinical outcomes, safety and efficacy of Eyecryl posterior-chamber phakic intraocular lens implantation (pIOL) implantation in patients with high myopia.
Methods: Patients with myopia between -6.00 and -20.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!